Source: Eur Respir J 2001; 18: 796-800
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Currie A.E., Vyas J.R., MacDonald J., Field D., Kotecha S.. Epidermal growth factor in the lungs of infants developing chronic lung disease. Eur Respir J 2001; 18: 796-800

Member's Comments

No comment yet.

Related content which might interest you: Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Source: Eur Respir J 2003; 21: 842-847 Year: 2003 Increased vascular endothelial growth factor in acute eosinophilic pneumonia Source: Eur Respir J 2003; 21: 774-778 Year: 2003 Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Source: Eur Respir J 2007; 30: 31-39 Year: 2007 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006 Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001 Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor Source: Eur Respir J 2008; 31: 714-724 Year: 2008 Decrease of vascular endothelial growth factor in macrophages from long-term smokers Source: Eur Respir J 2005; 25: 626-633 Year: 2005 Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts Source: Eur Respir J 2008; 31: 21-28 Year: 2008 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001 Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Fibroblast growth factor 23 and Klotho contribute to airway inflammation Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018 Year: 2018 Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002